Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 15/20 | 0.54 |
| ▸ | CFD | P00746 | 6/20 | 0.51 |
| ▸ | PLG | P00747 | 10/20 | 0.47 |
| ▸ | F11 | P03951 | 2/20 | 0.47 |
| ▸ | TPSB2 | P20231 | 2/20 | 0.47 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.47 |
| ▸ | F7 | P08709 | 1/20 | 0.47 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.43 |
| ▸ | PLAT | P00750 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5581641 | 0.87 | PLAU (0.52) | PLAUPLGPLAT | |
| SCHEMBL5581407 | 0.87 | PLAU (0.49) | PLAUCFDPLGF11TPSB2 | |
| SCHEMBL5581492 | 0.82 | PLAU (0.46) | PLAUCFDPLGF11TPSB2 | |
| SCHEMBL5580775 | 0.81 | PLAU (0.53) | PLAUCFDPLGF11TPSB2 | |
| SCHEMBL5581200 | 0.80 | PLAU (0.46) | PLAUPLGPLAT | |
| SCHEMBL5581036 | 0.80 | PLAU (0.47) | PLAUPLGPLAT | |
| SCHEMBL5580997 | 0.79 | PLAU (0.47) | PLAUCFDPLGF11TPSB2 | |
| SCHEMBL5581303 | 0.76 | PLAU (0.48) | PLAUCFDPLGF11TPSB2 | |
| SCHEMBL5580874 | 0.76 | PLAU (0.51) | PLAUPLGPLAT | |
| Hydrochloric Acid SCHEMBL5580908 | 0.76 | PLAU (0.56) | PLAUCFDPLGPLAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070148164-A1 | Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto | BIOGEN IDEC MA INC. (US) | 2007-06-28 | — | — | US | disclosed |